References
[1] WHO | Newborn death and illness – WHO | World Health Organization. https://www.who.int > press materials.
[2] Fleishmann, C., Reichert, F., Cassini, A., Horner, R., et al. Global incidence and mortality of neonatal sepsis: a systematic review and meta-analysis. Arch Dis Child, 2021, 06(8): 745-752. Doi: 10.1136/archdischild-2020-320217.
[3] Chacko, B., Sohi, I. (2005). Early onset neonatal sepsis. The Indian Journal of Pediatrics, 2005, 72(1): 23-26.
[4] Mistry, M., Battacharaya, A., Parmar, T. K. (2021). Neonatal septicemia and current scenario of antibiotic sensitivity pattern-A study of blood vulture isolates in a tertiary care hospital, Rajkot. International Journal of Medical Microbiology and Tropical Diseases, 2021, 7(4): 222-226. Doi:10.18231/j.ijmmtd.2021.046.
[5] Weston, E. J., Pondo, T., Lewis, M. M., et al. (2011). The burden of invasive neonatal sepsis in the United States, 2005-2008. Pediatr. Infect. Dis. J., 2011, 30: 937-941.
[6] Liu, L., et al. The Lancet Global Health. 2019 Jun 1; 7(60): e721-34.
[7] McClure, E. M., et al. (2009). Seminars in Fetal and Neonatal Medicinem 2009, Aug 1 (vol. 14, No. 4, pp. 182-189).
[8] Zaidi, A. K. M., Durrane, T., Asad, A. S., et al. (2009). Pathogens associated with sepsis in newborns and young infants in developing countries. The Pediatric Infectious Disease Journal, 2009, vol. 28(1): S10-S18. doi: 10.1097/INF.0b013e3191958769.
[9] Polin, R. A., St Geme, J. W. III Neonatal sepsis. Adv. Pediatr, Infect. Dis., 7: 25-61.
[10] Díaz, M. G., García, R. P., Gamero, D. B., González-Tomé, M. I., Romero, P. C., Ferrer, M. M., et al. (2016). Lack of accuracy of biomarkers and physical examination to detect bacterial infection in febrile infants. Pediatr Emerg Care, 2016, 32: 664-668.
[11] United Nations. (2017). Resolution adopted by the General Assembly on 6 July 2017, Work of the Statistical Commission pertaining to the 2030 Agenda for Sustainable Development (A/RES/71/313).
[12] Lawn, J. E., Cousens, S., Zupan, J. (2005). Four million neonatal deaths: where? When? Why? Neonatal survival series Paper 1. Lancet, 2005, 365: 891-900.
[13] Lawn, J. E., Wilczynska-Ketende, K., Cousens, S. N. (2006). Estimating the cause of 4 million neonatal deaths in the year 2000. Int. J Epidemiol., 2006, 35: 706-718.
[14] Sankar, M. J., Neogi, S. B., Sharma, J., Chauhan, M., Srivasta, R., et al. (2016). State of newborn health in India. Journal of Perinatology, 2016, 36: 53-58. Doi: 10.1038/jp.2016.183. https://www.ncbi.nim.nih.gov/pmc/articles/PMC5144119/.
[15] Ranjeva, S. L., Warf, B. C., Schiff, S. J. (2018). Economic burden of neonatal sepsis in Sub-Saharan Africa. BMJ Glob Health, 2018, 3: e000347. Doi: 10.1136/bmjgh-2017-000347. pmid:http://www.ncbi.nim.nih.gov/pubmed/29564153.
[16] Neonatal mortality -UNICEF DATA data.unicef.org https://data.unicef.org>child survival.
[17] Newborns: improving survival and well-being. (2020). https://www.who.int/news-room/fact-sheets/detail/newborns-reducing -mortality.
[18] Edwards, M. S., Baker, C. J. Sepsis in Newborn In Gershon AA, Hotex PJ, Katz SL. (ed.), Krugman’s infectious diseases of children 11th ED. Mosby, Philadelphia, PA 2004; pp. 545-561.
[19] Mathur, N. B., Kahlil, A., Sarkar, R., Puri, R. K. (1991). Mortality in neonatal septicemia with involvement of mother in management. Indian Pediatrics, 1991, 28(11): 1259-62.
[20] Grace Lalana Christopher. (2020). ‘Early Neonatal Mortality’ Recent Advances in Perinatology with specific reference to ethnicity. 3rd Edition, Published by Dr. Grace Lalana Publication. 2020 https://www.newgenparenting.com.
[21] Polin, R. A. (2012). Committee on fetus and Newborn Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics, 2012, 129: 1006-1015. doi: 10.1542/peds.2012-0541.
[22] Pavan Kumar, D. V., Mohan, J., Rakesh, P. S., Prasad, J., Joseph, L. (2017). Bacteriological profile of neonatal sepsis in a sec-ondary care hospital; in rural; Tamil Nadu, Southern India. J Family Med. Prim Care, 2017, 6: 735-8.
[23] Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Harris, M., Annane, D., Bauer, M., et al. (2016). The Third international consensus definitions for sepsis and septic shock. JAMA, 2016, 315: 801-10. Doi: 10.1001/jama.2016.0287.
[24] Gordon, S. M., Srinivasan, L., Harris, M. C. (2017). Neonatal meningitis: overcoming challenge in diagnosis, prognosis and treatment with omics. Front Pediatr., 2017, 5: 139. 10.3389/fped.2017.00139.
[25] Zarkesh, M., Sedaghat, F., Heidarzadeh, A., Tabrizi, M., Bolooki-Moghadam, K., Ghesmati, S. (2015). Diagnostic value of I8L-6, CRP, WBC, and absolute neutrophil count to predict serious bacterial infection in febrile infants. Acta Med Iran., 2015, 53: 408-11.
[26] Christopher, P. H., Benjamin, D. K., Becker, K. C., et al. (2012). Use of the complete blood cell count in early-onset neonatal sepsis. The Pediatric infectious disease journal, 2012, 31(8), 799.
[27] Manroe, B. L., Weinberg, A. G., Rosenfeld, C. R., Browne, R. (1979). The neonatal blood count in health and disease. 1. Reference value for neutrophilic count cells. J Pediatr, 1979, 95: 89-98.
[28] Bentitz, W. E., Han, M. Y., Madan, A., Ramachandra, P. (1998). Serial serum C- reactive protein levels in diagnosis of neonatal infection. Pediatrics, 1998, 102, E4110.1542/PEDS.102.4.E41.
[29] Garland, S. M., Bowman. (eds.) (2003). Reappraisal of C-reactive protein as a screening tool for neonatal sepsis. Pathology, 2003, 35: 240-243.
[30] Nuntnarumit, P., Pinkaew, O., Kitiwanwanich, S. (2002). Predictive values of serial C- reactive protein in neonatal sepsis. J Med Assoc Thai., 2002, (85 Suppl 4): S1151-1158.
[31] Fowlie, P. W., Schmidt, B. (1998). Diagnostic tests for bacterial infection from birth to 90 days: a systemic review. Arch Dis Fetal Neonatal Ed., 1998, 78:792-98.
[32] Guibourdenche, J., Bedu, A., Petzold, L., et al. (2002). Biochemical markers of neonatal sepsis: value of procalcitonin in the emergency setting. Ann Clin Biochem., 2002, 39: 130-135.
[33] Monneret, G., Labune, J. M., Isaac, C., Bienvenu, F., Putet, G., Bienvenu, J. (1997). Procalcitonin and C- reactive protein levels in neonatal infection. Act Pediatr., 1997, 86: 209-212. 10.1111/j.1651-2227.1997.tb08870.x.
[34] Kuzniewicz, M. W., Walsh, E. M., Li, S., Fischer, A., et al. (2016). Development and implementation of an early onset sepsis calculator to guide antibiotic management in late preterm and term neonates. JT Comm J Qual Patient Saf., 2016: 42(5): 232-9. PMID: 27066927. https://Neonatalsepsiscalculator.kaiserpermanente.org/.
[35] Rajbhandari, S., La Gamma, E. F. (2017). Early onset sepsis Calculator –risk of delaying treatment. JAMA Pediatr., 2017, 171(10): 1015. Doi:10.1001/jamapediatrics.2017.2476.
[36] Kochi-Lynch, M., et al. (2017). Positive blood culture is defined as gold standard for diagnosis of sepsis. Clinical infectious diseases, 2017, 6; 65(suppl): S190-9.
[37] Hurst, M. K., Yoder, B. A. (1995). Detection of bacteremia in young infants: Is 48 hours adequate? Pediatr. Infect. Dis. J., 1995, 14: 711-3.
[38] Sherris, John C., Ryan, Kenneth J., Ray, C. L. (2004). Sherris medical microbiology; an introduction to infectious diseases. New York: McGraw-Hill. 2004, Principles of Laboratory Diagnosis. ISBN 978-0-8385-8529-0.
[39] Rohner, P., Pepey, B., Auckenthaler, R. (1997). Advantage of combining resin with lytic BACTEC blood culture media. J Clin Microbiol., 1997, 35(10): 2634-2638. PMCID: PMC230024 | PMID:0316921,
[40] Venkatesh, M., Flores, A., Luna, R. A., Versalovic, J. (2010). Molecular microbiological methods in the diagnosis of neonatal sepsis. Expert Rev. Anti Infec. Ther., 2010, 8: 1037-1048. 10.1586/eri.10.89.
[41] Jordan, J. A., Durso, M. B. (2005). Real time polymerase chain reaction for detecting bacterial DNA directly from blood stream of neonates being evaluated for sepsis J. Mol. Diagn., 2005: 7:575-581.10.1016/S1525-1578(10)60590-9.
[42] Shang, S., Chen, G., Wu, Y., Zhao. (2005). Rapid diagnosis of bacterial sepsis with PCR amplification and Microarray Hybridization in 16S r RNA gene. Pediatr Res., 2005, 58: 143-148. 10.1203/01.PDR.0000169580.64191.8B.
[43] Mehr S, Doyle LW. Cytokines as markers of bacterial sepsis in newborn infants; a review. Pediatr Infect Dis J 200019879-887.
[44] Kuster, H., Weiss, M., Willeitner, A. E., et al. (1998). Interleukin -1 Receptor antagonist and interleukin -6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet, 1998, 352: 1271-1277.10.1016/S0140-6736 (98)08148-3.
[45] Ng, P. C. Diagnostic markers of infection in neonates. Arch Dis Fetal Neonatal Ed. 200489F229-F235.
[46] Hedegaard, S. S., Wisborg, K., Hvas, A. M. (2015). Diagnostic utility of biomarkers for neonatal sepsis-a systematic review. Infect Dis (Lond), 2015, 47(3): 117-124. Doi: 10.3109/00365548.2014.971053.
[47] Ng, P. C., Cheng, S. H., Chui, K. M., et al. Diagnosis of late onset neonatal sepsis with cytokine, adhesion molecule and C-reactive protein in preterm very low birth weight infants. Arch Dis Fetal Neonatal Ed., 199777F221-F227.
[48] Park, K. H., Yoon, B. H., Shim, S. S., et al. Amniotic fluid necrosis factor-alpha is a marker for the prediction of early onset neonatal sepsis in preterm labor. Gynecol Obstet Invest, 20045884-90.
[49] Berner, R., Tuxen, B., Clad, A., et al. Elevated gene expression of interleukin-8 in cord blood is a sensitive marker for neonatal infection. Eur J Pediatr., 2000159205-210.
[50] Tang, N., Tornatore, P., Weinberger, S. R. (2004). “Current developments in SELDI affinity technology”. Mass Spectrometry Reviews, 2004, 23(1): 34-44.
[51] Thayi, S., Paramahamsa, R. (2016). Outcome of newborns born to mothers with prolonged rupture of membrane. Pediatric Review: International Journal of Pediatric Research, 2016, 3(11).
[52] Boskabadi, H., Maamouri, G., Mafinejad, S. (2011). Neonatal complications related with prolonged rupture of membranes. Macedionian Journal of Medical Sciences, 2011, 4: 93-98. doi:10.3889/MJMS.1857-5773.2011.0159.
[53] Laranjo, M., Maia, C. J., Botelho, M. F. (2012). Amniotic membrane: from structure and functions to clinical applications. Cell Tissue Res., 2012, 349(2): 447-458. Doi: 10.1007/s00441-012-1424-6.
[54] Garland, S. M., Ni Chuileannain, F., Satzke, C., et al. (2002). Mechanism, organisms and markers of infection in pregnancy. J Reprod Immunol., 2002, 57: 169-183.
[55] Simonsen, K. A., Anderson-Berry, A. L., Delair, S. F., Davies, H. D. (2014). Early onset neonatal sepsis. Clin Microbiol Rev., 2014, 27(1): 21-47. Doi:10.1128/CMR.00031-13.
[56] Knowles, S. J., O’Sullivan, N. P., A. M. Meenan, Hanniffy, R., Robson, M. (2015). Maternal sepsis incidence, etiology and outcome for mother and fetus: a prospective study. BJOG, 2015, 122(5): 663-71. PMID: 24862293 doi:10.1111/1471-0528.12892.
[57] Puopolo, K. M., Lynfield, R., Cummimgs, J. J., et al. (2019). Management of infants at risk for Group B streptococcal disease. Pediatrics, 2019, 144(2): e20191881. doi:10.1542/peds.2019-1881.
[58] Schrag, S. J., Zywicki, S., Farley, M. M., Reingold, A. L., Harrison, L. H., et al. (2000). Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med., 2000, 342: 15-20.
[59] Ibrahim, U., Panti, A., Mohammed, Y., et al. (2012). Risk factors for Group B Streptococcus Colonization and Drugs sensitivity Pattern in Nigerian Obstetric Population. Open Journal of Obstetrics and Gynecology, 2012, 11: 808-814. Doi 10.4236ojog.2021.116074.
[60] Cloouse, K., Shebabi, A., Suleimat, A. M., et al. (2019). High prevalence of Group B Streptococcus colonization among pregnant women in Amman, Jordan, BMC Pregnancy and Children, 2019, 177: 19. https://doi.org/10.1186/s12884-019-2317-4.
[61] Melissa, K. V. D. (2009). Evaluation of universal antenatal screening for Group B streptococcus. The New England Journal of Medicine, 2009, 360: 2626-2636.
[62] Schuchat, A. (2000). Neonatal group B streptococcal disease-screening and prevention. N. Engl. J Med., 2000, 343: 209-210.
[63] Tewari, V. V., Jain, N. (2014). Monotherapy with amikacin or piperacillin-tazobactum empirically in neonates at risk for early-onset sepsis: a randomized controlled trial J. Trop Pediatr., 2014, 60(4): 297-302. 10.1093/tropej/fmu017.